(Press-News.org) Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) and Southern Alberta Cancer Research Institute (SACRI) have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.
Researchers used tumour cells derived from 100 different glioblastoma patients to test drugs that could target the disease. When these human brain tumour-initiating cells were inserted into an animal model, researchers discovered that when using a drug, AZD8055, combined with Temozolomide (TMZ) – a drug already taken by most glioblastoma patients – the life of the animals was extended by 30 per cent.
"Shutting off vital tumour growth processes can lead to the death of human brain tumour-initiating cells. Our research has identified a key process in brain tumour growth that we were able to target with AZD8055," says Luchman from the university's Cumming School of Medicine and a member of the HBI.
Researchers used the new therapy to inhibit a pathway in the cancer cells known as mTOR signaling – putting the brakes on this pathway, combined with the current standard therapy, caused more of the cancer cells to die. Scientists are now working with investigators at the NCIC Clinical Trials Group (NCIC-CTG) to start a Canadian clinical trial that may eventually include glioblastoma patients across the country.
"Discovering new pathways and therapies that can be tested in the clinic provides the greatest hope for brain cancer patients and their families," says Weiss, leader of the university's Brain and Mental Health strategic research priority.
Glioblastoma is the most common and deadly form of brain cancer among adults. The progression and complexity of the tumours are often difficult to treat. The median survival for patients is 15 months, with less than five per cent of patients surviving beyond five years.
University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross – director of SACRI, and leader of the Terry Fox Research Institute (TFRI) 'Therapeutic Targeting of Glioblastoma research program at the university – are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.
"This is an important initiative – to test new drugs, being developed for other types of cancers in the laboratory to identify which are most promising for testing in patients with glioblastoma. NCIC CTG is excited to partner in the development of this clinical trial, which will be funded by a grant from the TFRI as well as grants from Canadian Cancer Society Research Institute to NCIC CTG," says Seymour.
INFORMATION:
The study was funded by the Alberta Cancer Foundation, Alberta Innovates-Health Solutions and the Canadian Stem Cell Network.
University of Calgary research leads to brain cancer clinical trial
2014-10-14
ELSE PRESS RELEASES FROM THIS DATE:
Thyroid carcinoma: Biomarker reveals cancer cause
2014-10-14
CLIP2 serves as a radiation marker: After exposure to radiation from radioiodine, both the genetic activity and the protein expression are increased, as the scientists' studies were able to substantiate.
CLIP2 appears to be particularly significant in the development of tumours in the thyroid gland after radiation exposure. The team around Martin Selmansberger, Dr. Julia Heß, Dr. Kristian Unger and Prof. Dr. Horst Zitzelsberger from the Radiation Cytogenetics Research Unit at the Helmholtz Zentrum München discovered a connection between high CLIP2 levels and ...
CWRU studies how women in recovery manage personal networks with family and friend users
2014-10-14
Substance abuse counselors and social workers often recommend recovering addicts establish new networks of non-using friends and supporters.
But researchers at Case Western Reserve University's social work school found, for many women in poverty, it's not so easy to drop the users in their lives. Many are people that women depend on for childcare, transportation and other necessities to live.
"People in the women's networks might be family members, parents or children, who also use drugs. It's hard to cut these people out of their lives," said Elizabeth M. Tracy, ...
A neurotic personality increases the risk of Alzheimer's disease
2014-10-14
Women who worry, cope poorly with stress and/or experience mood swings in middle age run a higher risk of developing Alzheimer disease later in life. This is the conclusion of a study carried out at the Sahlgrenska Academy, University of Gothenburg, that followed 800 women for nearly 40 years.
The study, which will be published in the scientific journal Neurology, started in 1968 when 800 women in Gothenburg took a personality test that measured, among other things, their levels of neuroticism and extroversion.
High Stress
The women in the study stated whether they ...
CWRU dental survey finds dental anxiety leads cause for moderate sedation
2014-10-14
Dental anxiety can be so extreme for some patients that a simple cotton swab on the gums makes them flinch. And others, fearful of pain, simply avoid seeing the dentist, according to a new study by Case Western Reserve University dental researchers on when and how to use sedatives during dental procedures.
As a result, dentistry is responding with sedation techniques to make fearful and anxious patients more comfortable.
For a master's thesis in endodontics, Madhavi Setty, DDS, MSD, set out to understand how dental specialties like endodontics for root canals, periodontics ...
NASA sees a weaker Typhoon Vongfong near Amami Oshima
2014-10-14
The once-powerful Category 5 Typhoon Vongfong has fortunately weakened to a barely Category 1 typhoon as it approaches the big islands of Japan. NASA-NOAA's Suomi NPP satellite and NASA's Aqua satellite passed over Vongfong on Oct. 11 and noticed the heaviest precipitation was north of the center.
NASA-NOAA's Suomi NPP satellite passed over Vongfong on Oct. 11 at 17:23 UTC (1:23 p.m. EDT) and captured an infrared image of the storm from the VIIRS instrument. The VIIRS instrument showed that the strongest thunderstorms that stretched highest in the atmosphere were in the ...
NASA sees Cyclone Hudhud approaching India's coast
2014-10-14
NASA's Aqua satellite passed over Cyclone Hudhud as it was nearing east-central India's coastline on Oct. 11.
The Atmospheric Infrared Sounder or AIRS instrument aboard Aqua captured infrared data on the storm on Oct. 11 at 07:23 UTC (3:23 a.m. EDT) that showed cloud top temperatures had dropped, indicating stronger uplift and stronger thunderstorms. That's an indication that the storm has strengthened in the last day.
The Joint Typhoon Warning Center noted that animated infrared satellite imagery shows the eye feature has become cloud filled while the overall structure ...
Satellite sees cold front headed to absorb Bermuda's Tropical Storm Fay
2014-10-14
VIDEO:
This animation of imagery from NOAA GOES-East satellite from Oct. 10-12 shows the movement of Tropical Storm Fay in the Atlantic an approaching cold front over the eastern US....
Click here for more information.
Tropical Storm Fay is affecting Bermuda on Sunday, Oct. 12, but a cold front over the eastern U.S. is expected to absorb the storm over the next day or two. Both were seen in an image from NOAA's GOES-East satellite.
On Saturday, Oct. 11, Tropical Depression 7 ...
NASA sees newborn Tropical Storm Gonzalo form and threaten Caribbean islands
2014-10-14
Tropical Storm Gonzalo formed quickly on Oct. 12 just east of the Leeward Islands, triggering tropical storm warnings for many islands. NOAA's GOES-East satellite captured an image of the newborn storm on Sunday, Oct. 12, and Tropical Storm Fay northeast of Bermuda.
The GOES East satellite is a geostationary satellite managed by NOAA. At NASA's Goddard Space Flight Center in Greenbelt, Maryland the NASA/NOAA GOES Project creates images and animations and today's visible image, taken at 2:45 p.m. EDT showed a smaller Gonzalvo east of the Leeward Islands while Fay was ...
One gene links susceptibility to rare infections with predisposition to autoimmune disease
2014-10-14
The mutations were familiar, but the patients' conditions seemed baffling at first. A team lead by Rockefeller University researchers had linked variations in an immune gene to rare bacterial infections. Shortly afterward, Chinese scientists told them of three children in that country with mutated versions of the same gene. However, the Chinese children had no history of the severe bacterial infections. Instead, they had seizures and unusual calcium deposits deep in their brains.
This discrepancy led to the discovery of an immune protein with paradoxical roles: It both ...
Antibiotic resistance: Bacterial defense policies
2014-10-14
High-resolution cryo-electron microscopy has now revealed in unprecedented detail the structural changes in the bacterial ribosome which results in resistance to the antibiotic erythromycin.
Multiresistant bacterial pathogens that are insensitive to virtually all available antibiotics are one of the major public-health challenges of our time. The question of how resistance to various antibiotics develops is the focus of research being carried out by Ludwig-Maximilians-Universitaet (LMU) in Munich biochemist Daniel Wilson and his colleagues. As they report in the journal ...